PATENT CLAIM ANALYSIS

Application Number: 16002297
Application Type: Utility
Filing Date: 2018-06
Publication Date: 2018-10
Patent Classification: ["514", "233800"]

Abstract:
The present invention provides a compound having a particular chemical structure or a pharmacologically acceptable salt thereof which has an excellent inhibitory effect on EZH1 and/or EZH2 activity. The present invention provides a compound having a 1,3-benzodioxole structure represented by the general formula (I) or a pharmacologically acceptable salt thereof, or a pharmaceutical composition comprising the compound (wherein R 1 , R 2 , R 3 , R 4 , R 5 , R 6 , and V in the formula (I) are each as defined in the present specification).

Claim (Index 17):
The method of  claim 15 , wherein the cancer has a somatic mutation in EZH2.

Metadata:
- Claim Count in Document: 38.0
- Percentile: 94.0
- Lexical Diversity: 1.76786
- Patent Class: 514.0
- Transitional Phrase Type: none
- Component Type: 0
- Foreign Priority: True
- Related Applications: ['15123523', '15742478', '14110873', '13796437', '14536162']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.810581944266576
- 35 USC 102 Novelty (BERT): 0.5971467779145085
- Combined Prediction Score: 0.7892384276313693
- Mean Citation Score: 468.236094
- Max Citation Score: 650.5967400000002
- Similarity Product: 399.4832816263463

Labels:
- Claim Label 101: 1
- Claim Label 102: 1
- Claim Label 103: 1
- Claim Label 112: 0
- Combined Label: 1
- Label 101 Adjusted: 1

Dataset: test